ENHANCING MEN'S HEALTHCARE IN PAKISTAN: A FOCUS ON PROSTATE CANCER SCREENING AND INTERVENTION

Main Article Content

Amira Shahid Sheikh
Aqib Zaman Kheljee
Ghazi Uddin Ahmed
Saleemullah
Erma Hussain
Amirah Fahad Alshammeri

Keywords

Abstract

Background: Benign prostatic hyperplasia (BPH) is a common condition in aging males, characterized by an enlarged prostate gland. This progressive condition can lead to bothersome lower urinary tract symptoms (LUTS) that significantly impact quality of life.


Methods: This review article discusses the signs and symptoms of BPH, methods for diagnosis, and treatment options.


Results:



  • Signs and Symptoms: BPH can cause obstructive and irritative LUTS. Obstructive symptoms include hesitancy, reduced urinary flow rate, and incomplete bladder emptying. Irritative symptoms include nocturia, urgency, and frequency.

  • Diagnosis: Diagnosis of BPH involves a detailed medical history, physical examination, and potentially additional tests such as digital rectal examination, International Prostate Symptom Score (I-PSS), prostate specific antigen (PSA) test, and uroflowmetry.

  • Treatment: Treatment options for BPH depend on the severity of symptoms and patient factors. Conservative management may be appropriate for mild symptoms. Medications such as alpha-adrenergic receptor blockers and 5-alpha reductase inhibitors can improve symptoms. Minimally invasive surgical procedures like transurethral resection of the prostate (TURP) are used for moderate to severe BPH.


Conclusion: BPH is a prevalent condition in older men. Early diagnosis and appropriate treatment can significantly improve quality of life for patients with BPH.

Abstract 109 | PDF Downloads 43

References

1. Abdelmoteleb, H., et al. (2020). The lower urinary tract symptoms. Lower Urinary Tract Symptoms in Adults, Springer: 19-38.
2. Bauersachs, J. and N. López‐Andrés (2022). "Mineralocorticoid receptor in cardiovascular diseases—Clinical trials and mechanistic insights." British Journal of Pharmacology 179(13): 3119-3134.
3. Bordeianou, L. G., et al. (2020). " Female Pelvic Medicine and Urogenital Reconstruction." Techniques in coloproctology 24(1): 5-22.
4. Brady, L., et al. (2021). "Inter-and intra-tumour heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling." Nature communications 12(1): 1-16.
5. Breheny, C. et al. (2022). "Approach to urethral obstruction in cats. Part 1: presentation and stabilization." In Practice 44(7): 372-384.
6. Fossati, N., et al. (2020). "Newly diagnosed oligometastatic prostate cancer: current controversies and future developments." European Urology Oncology.
7. Infantino, M., et al. (2020). "Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives." Isr Med Assoc J 22(4): 203-210.
8. Kocjancic, E., et al. (2022). "International Continence Society (ICS) report on the terminology for sexual health in men with lower urinary tract (LUT) and pelvic floor (PF) dysfunction." Neurourology and Urodynamics 41(1): 140-165.
9. Lei, Y., et al. (2019). "Ultrasound prostate segmentation based on multidirectional deeply supervised V‐Net." Medical physics 46(7): 3194-3206.
10. Lerner, L. B., et al. (2021). "Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II—surgical evaluation and treatment." The Journal of Urology 206(4): 818-826.
11. Liao, J., et al. (2019). "Transurethral resection of the prostate with preservation of the bladder neck decreases postoperative retrograde ejaculation." Videosurgery and Other Miniinvasive Techniques 14(1): 96-101.
12. Mauvais-Jarvis, F., et al. (2021). "Sex-and gender-based pharmacological response to drugs." Pharmacological reviews 73(2): 730-762.
13. Pignolo, R. J. (2019). Exceptional human longevity. Mayo Clinic Proceedings, Elsevier.
14. Schlegel, P. N., et al. (2021). "Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I." The Journal of Urology 205(1): 36-43.
15. Sharma, S. et al. (2019). "In-situ fast gelling formulation for oral sustained drug delivery of paracetamol to dysphagic patients." International journal of biological macromolecules 134: 864-868.
16. Starrs, A. M., et al. (2018). "Accelerate progress—sexual and reproductive health and rights for all: report of the Guttmacher–Lancet Commission." The Lancet 391(10140): 2642-2692.
17. Su, H. et al. (2020). "Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China." Kidney international 98(1): 219-227.
18. Sung, V. W., et al. (2019). "Effect of behavioural and pelvic floor muscle therapy combined with surgery vs surgery alone on incontinence symptoms among women with mixed urinary incontinence: the ESTEEM randomized clinical trial." Jama 322(11): 1066-1076.
19. Van Leeuwen, K. M., et al. (2019). "What does the quality of life mean to older adults? A thematic synthesis." PLoS ONE 14(3): e0213263.
20. Vilela, A. and T. Pinto (2019). "Grape infusions: The flavour of grapes and health-promoting compounds in your teacup." Beverages 5(3): 48.
21. Wechsler, M. E., et al. (2020). "SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma." Respiratory Research 21(1): 1-10.
22. Wilson, J. et al. (2022). "Urinary tract obstruction." InnovAiT 15(5): 265-271.

Most read articles by the same author(s)

1 2 > >>